Hikma Pharmaceutical reported 2M in Cash and Equivalent for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
AstraZeneca AZN:LN 15567M 7931M
Bayer BAYN:GR € 3389M 2161M
Fresenius FRE:GR € 2250M 373M
Fresenius Medical Care FMS:US $ 1408M 334.52M
Genmab GEN:DC DK 9477M 1585M
GlaxoSmithKline GSK:LN 3503M 1254M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Lonza Group LONN:SW 501M 6M
Merck MRK:GR € 1825M 413M
Orion ORNBV:FH € 156.3M 2.7M
Recordati REC:IM € 271.87M 21.78M